Board Meeting
The next board meeting for RVL Pharmaceuticals plc is on 01 Aug 2025 for the purpose of RVL Pharmaceuticals PLC First Quarter Earnings Result for 2025 See details


Insider Trading disclosures for RVL Pharmaceuticals plc

The latest disclosure was made by Alisa Lask in RVL Pharmaceuticals plc where a trade of 12,000 Ordinary Shares done at an average price of $0.5 was reported to US exchanges on Aug. 10, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Alisa Lask Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.49 per share. 10 Aug 2023 12,000 112,557 (0%) 0% 0.5 5,880 Ordinary Shares
Gregory L. Cowan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jul 2023 40,000 90,055 (0%) 0% 0 Ordinary Shares
Michael DeBiasi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jul 2023 40,000 40,000 (0%) 0% 0 Ordinary Shares
Alisa Lask Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jul 2023 40,000 124,557 (0%) 0% 0 Ordinary Shares
James Schaub EVP and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.87 per share. 18 May 2023 5,577 524,835 (0%) 0% 0.9 4,852 Ordinary Shares
Christopher Klein General Counsel & Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.87 per share. 18 May 2023 5,447 180,573 (0%) 0% 0.9 4,739 Ordinary Shares
Sriram Venkataraman Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 27 Jan 2023 1,032,995 0 (0%) 1% 0 Ordinary Shares
David F. Burgstahler Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 27 Jan 2023 1,032,995 0 (0%) 1% 0 Ordinary Shares
James Schaub EVP and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.26 per share. 24 Jan 2023 9,608 530,412 (0%) 0% 1.3 12,106 Ordinary Shares
Christopher Klein General Counsel & Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.26 per share. 24 Jan 2023 9,608 186,020 (0%) 0% 1.3 12,106 Ordinary Shares
Alisa Lask Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2022 75,000 84,557 (0%) 0% 0 Ordinary Shares
Brian A. Markison Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.55 per share. 08 Aug 2022 850,000 2,976,020 (5%) 1% 1.6 1,317,500 Ordinary Shares
David F. Burgstahler Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.55 per share. 08 Aug 2022 8,000,000 23,730,864 (40%) 13% 1.6 12,400,000 Ordinary Shares
Sriram Venkataraman Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.55 per share. 08 Aug 2022 8,000,000 23,730,864 (40%) 13% 1.6 12,400,000 Ordinary Shares
James Schaub EVP and COO Purchase of securities on an exchange or from another person at price $ 1.55 per share. 08 Aug 2022 150,000 540,020 (0%) 0% 1.6 232,500 Ordinary Shares
James Schaub EVP and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.40 per share. 18 May 2022 6,273 390,020 (0%) 0% 1.4 8,782 Ordinary Shares
Christopher Klein General Counsel & Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.40 per share. 18 May 2022 6,127 195,628 (0%) 0% 1.4 8,578 Ordinary Shares
Tina deVries EVP, Research & Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.40 per share. 18 May 2022 5,447 136,141 (0%) 0% 1.4 7,626 Ordinary Shares
Andrew J. Einhorn Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.13 per share. 24 Jan 2022 9,607 141,473 (0%) 0% 1.1 10,856 Ordinary Shares
Tina deVries EVP, Research & Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.13 per share. 24 Jan 2022 9,607 141,588 (0%) 0% 1.1 10,856 Ordinary Shares
Christopher Klein General Counsel & Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.13 per share. 24 Jan 2022 9,607 201,755 (0%) 0% 1.1 10,856 Ordinary Shares
James Schaub EVP and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.13 per share. 24 Jan 2022 9,607 396,293 (0%) 0% 1.1 10,856 Ordinary Shares
James Schaub EVP and COO Purchase of securities on an exchange or from another person at price $ 1.07 per share. 16 Dec 2021 93,800 405,900 (0%) 0% 1.1 100,366 Ordinary Shares
James Schaub EVP and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2021 249,814 249,814 - - Share Option (Right to Buy)
Christopher Klein General Counsel & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2021 249,814 249,814 - - Share Option (Right to Buy)
Tina deVries EVP, Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2021 216,944 216,944 - - Share Option (Right to Buy)
Andrew J. Einhorn Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2021 249,814 249,814 - - Share Option (Right to Buy)
Brian A. Markison Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2021 615,000 615,000 - - Share Option (Right to Buy)
Fred G. Weiss Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.31 per share. 27 Aug 2021 5,506 118,466 (0%) 0% 3.3 18,225 Ordinary Shares
Gregory L. Cowan Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.31 per share. 27 Aug 2021 5,506 50,055 (0%) 0% 3.3 18,225 Ordinary Shares
Fred G. Weiss Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jul 2021 61,188 123,972 (0%) 0% 0 Ordinary Shares
Fred G. Weiss Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.89 per share. 18 Jun 2021 18,584 62,784 (0%) 0% 2.9 53,708 Ordinary Shares
Gregory L. Cowan Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.89 per share. 18 Jun 2021 18,584 55,561 (0%) 0% 2.9 53,708 Ordinary Shares
James Schaub EVP and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.12 per share. 18 May 2021 6,621 312,100 (0%) 0% 3.1 20,658 Ordinary Shares
Christopher Klein General Counsel & Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.12 per share. 18 May 2021 6,467 211,362 (0%) 0% 3.1 20,177 Ordinary Shares
Tina deVries EVP, Research & Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.12 per share. 18 May 2021 6,467 151,195 (0%) 0% 3.1 20,177 Ordinary Shares
Andrew J. Einhorn Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.12 per share. 18 May 2021 6,467 151,080 (0%) 0% 3.1 20,177 Ordinary Shares
James Schaub EVP and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.46 per share. 24 Jan 2021 9,687 318,721 (0%) 0% 4.5 43,204 Ordinary Shares
Christopher Klein General Counsel & Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.46 per share. 24 Jan 2021 9,605 217,829 (0%) 0% 4.5 42,838 Ordinary Shares
Tina deVries EVP, Research & Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.46 per share. 24 Jan 2021 9,597 157,662 (0%) 0% 4.5 42,803 Ordinary Shares
Andrew J. Einhorn Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.46 per share. 24 Jan 2021 9,668 157,547 (0%) 0% 4.5 43,119 Ordinary Shares
Gregory L. Cowan Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.46 per share. 24 Jan 2021 5,505 74,145 (0%) 0% 4.5 24,552 Ordinary Shares
Fred G. Weiss Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.46 per share. 24 Jan 2021 5,505 81,368 (0%) 0% 4.5 24,552 Ordinary Shares
David F. Burgstahler Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 20 Nov 2020 4,936,926 0 (0%) 8% - Ordinary Shares
Sriram Venkataraman Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 20 Nov 2020 4,936,926 0 (0%) 8% - Ordinary Shares
Gregory L. Cowan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2020 38,716 90,762 (0%) 0% 0 Ordinary Shares
Gregory L. Cowan Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.60 per share. 20 May 2020 11,112 79,650 (0%) 0% 4.6 51,115 Ordinary Shares
Fred G. Weiss Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.60 per share. 20 May 2020 17,778 86,873 (0%) 0% 4.6 81,779 Ordinary Shares
Fred G. Weiss Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2020 38,716 104,651 (0%) 0% 0 Ordinary Shares
Brian A. Markison Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2020 249,787 2,126,020 (3%) 0% 0 Ordinary Shares
Brian A. Markison Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2020 249,787 249,787 - - Performance-Based Restricted Stock Units
James Schaub EVP and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 73,253 73,253 - - Performance-Based Restricted Stock Units
James Schaub EVP and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 73,253 328,408 (0%) 0% 0 Ordinary Shares
Christopher Klein General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 71,550 227,434 (0%) 0% 0 Ordinary Shares
Christopher Klein General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 71,550 71,550 - - Performance-Based Restricted Stock Units
Tina deVries EVP, Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 71,550 71,550 - - Performance-Based Restricted Stock Units
Tina deVries EVP, Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 71,550 167,259 (0%) 0% 0 Ordinary Shares
Andrew J. Einhorn Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 71,550 71,550 - - Performance-Based Restricted Stock Units
Andrew J. Einhorn Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2020 71,550 167,215 (0%) 0% 0 Ordinary Shares
Christopher Klein General Counsel & Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. 28 Jan 2020 9,148 155,884 (0%) 0% 7 64,036 Ordinary Shares
Fred G. Weiss Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. 28 Jan 2020 5,505 65,935 (0%) 0% 7 38,535 Ordinary Shares
Gregory L. Cowan Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. 28 Jan 2020 5,505 52,046 (0%) 0% 7 38,535 Ordinary Shares
Andrew J. Einhorn Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. 28 Jan 2020 9,184 95,665 (0%) 0% 7 64,288 Ordinary Shares
James Schaub EVP and COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. 28 Jan 2020 9,197 255,155 (0%) 0% 7 64,379 Ordinary Shares
Tina deVries EVP, Research & Development Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. 28 Jan 2020 9,140 95,709 (0%) 0% 7 63,980 Ordinary Shares
Sriram Venkataraman Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 5.00 per share. 13 Jan 2020 1,250,000 15,730,864 (26%) 2% 5 6,250,000 Ordinary Shares
David F. Burgstahler Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 5.00 per share. 13 Jan 2020 1,250,000 15,730,864 (26%) 2% 5 6,250,000 Ordinary Shares
Fred G. Weiss None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2019 37,037 71,440 (0%) 0% 0 Ordinary Shares
Gregory L. Cowan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2019 23,148 57,551 (0%) 0% 0 Ordinary Shares
Brian A. Markison Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2019 387,991 1,876,233 (3%) 0% 0 Ordinary Shares
James Schaub EVP and COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2019 104,849 264,352 (0%) 0% 0 Ordinary Shares
Christopher Klein General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2019 104,849 165,032 (0%) 0% 0 Ordinary Shares
Tina deVries EVP, Research & Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2019 104,849 104,849 (0%) 0% 0 Ordinary Shares
Andrew J. Einhorn Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2019 104,849 104,849 (0%) 0% 0 Ordinary Shares
Gregory L. Cowan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2019 34,403 34,403 (0%) 0% 0 Ordinary Shares
Fred G. Weiss None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2019 34,403 34,403 (0%) 0% 0 Ordinary Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures